Madison El-Saadi
Stock Analyst at B. Riley Securities
(2.85)
# 3,593
Out of 5,090 analysts
9
Total ratings
66.67%
Success rate
22.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Madison El-Saadi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $11 | $5.39 | +104.08% | 1 | Nov 5, 2025 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $179 | $149.22 | +19.96% | 1 | Oct 1, 2025 | |
| CAPR Capricor Therapeutics | Initiates: Buy | $21 | $26.89 | -21.90% | 1 | Jun 26, 2025 | |
| ETON Eton Pharmaceuticals | Reiterates: Buy | $24 → $26 | $16.26 | +59.90% | 3 | May 16, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $19 → $22 | $7.49 | +193.72% | 3 | Nov 4, 2024 |
Vanda Pharmaceuticals
Nov 5, 2025
Initiates: Buy
Price Target: $11
Current: $5.39
Upside: +104.08%
Axsome Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $179
Current: $149.22
Upside: +19.96%
Capricor Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $21
Current: $26.89
Upside: -21.90%
Eton Pharmaceuticals
May 16, 2025
Reiterates: Buy
Price Target: $24 → $26
Current: $16.26
Upside: +59.90%
Wave Life Sciences
Nov 4, 2024
Maintains: Buy
Price Target: $19 → $22
Current: $7.49
Upside: +193.72%